drug affinity complex comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-08-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.
Characterization of this peptide relies on a small set of routine techniques. Reversed-phase high-performance liquid chromatography separates the target from truncated or oxidized by-products and yields a purity estimate when paired with ultraviolet detection near 214 nanometers. Mass spectrometry, either electrospray coupled to liquid chromatography or matrix-assisted laser desorption, confirms that the observed mass matches the value calculated for the expected sequence. Amino acid analysis, and enzymatic digestion followed by fragment mapping, are used when the sequence itself rather than the mass requires verification.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Assessed by visual inspection under ordinary light |
| Primary analytical method | Reversed-phase liquid chromatography | Purity estimated from peak area at 214 nm |
| Confirmatory method | Mass spectrometry | Observed mass compared with calculated value |
| Powder storage temperature | Minus 20 degrees Celsius | Minus 80 for extended archival periods |
| Solution stability | Hours to days at 2 to 8 degrees Celsius | Influenced by pH, buffer, and concentration |
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
A Study published by Altus Group indicates that 383 pubs closed in England during the first six months of 2023, including 46 in London. 9 October – Medway Council in Kent cancels its 2023 Christmas lights due to what it describes as a "challenging financial situation". 11 October – South Yorkshire Police says it is making "ongoing" inquiries after video footage emerged of a man climbing onto the roof of Sheffield Town Hall to replace an Israeli flag with a Palestinian one. An Independent Monitoring Board report into Wandsworth Prison has concluded that the prison is "unsafe and inhumane"; the report was prepared before the escape of Daniel Khalife in September. 12 October – Following reports that some student societies have been distributing leaflets in support of Hamas, education ministers Gillian Keegan and Robert Halfon have written to university vice chancellors in England urging them to "act swiftly and decisively against any threats" to students' safety and welfare. The number of people waiting for planned NHS treatment in England rises to 7.75 million. 13 October – Three Jewish schools in north London have closed for the day amid safety concerns for their students because of the ongoing conflict between Israel and Hamas. Police have detailed a 22-year-old woman on suspicion of supporting Hamas, which is a prescribed terrorist organisation in the UK, following a speech given at a protest in Brighton on 8 October.
=== Analytical implementations === Surface plasmon resonance can be implemented in analytical instrumentation. SPR instruments consist of a light source, an input scheme, a prism with analyte interface, a detector, and computer. Any quantitative derivation relies on modelling the surface based on the boundary conditions of the Maxwell's equations, for plane films using the Fresnel equations.
=== September === 1 September – John Swinney gives his keynote speech to the SNP Annual Conference, saying that he will put the "people's priorities" at the heard of the Scottish Government, and that he will work to convince voters that Scottish independence is the "route" to delivering a fairer and stronger country. 2 September – The Scottish Government confirms that all young offenders under the age of 18 have been removed from Scotland's young offenders' institutions and transferred to more child-friendly accommodation. 3 September – In a statement to the Scottish Parliament, Finance Secretary Shona Robison outlines £500m of spending cuts. She argues the cuts are needed because of an additional £800m in financial costs brought about by public sector pay deals, austerity from Westminster, inflation, the COVID-19 pandemic and the Russian invasion of Ukraine. BBC News reports that the headquarters of GB Energy, the new government-backed energy company, will be in Aberdeen. Members of the Unison trade union working for councils in Scotland reject an annual pay increase offer worth 3.6%, equivalent to at least £1,292. 4 September – The Scottish Government abandons an unfulfilled commitment to expand free school meals to all primary school pupils. 5 September – Scottish rugby player Scott Hastings confirms his wife, Jenny Hastings, has been reported missing after disappearing at a location used for wild swimming in the Firth of Forth on 3 September.
Ioxaglic acid (trade name Hexabrix) is pharmaceutical drug used as an iodinated contrast medium for X-ray imaging. It has low osmolality (relatively few molecules per volume), typically resulting in fewer side effects than high-osmolality media. It is manufactured by Guerbet, but marketing in the US has been discontinued. As of 2021, it may still be available in some European countries. It is applied in form of its salts, ioxaglate meglumine and ioxaglate sodium.
=== Pharmacodynamics === Bremelanotide is a non-selective agonist of the melanocortin receptors, MC1 through MC5 (with the exception of MC2, the receptor of ACTHTooltip adrenocorticotropic hormone), but acting primarily as an MC3 and MC4 receptor agonist.
Sources: en.wikipedia.org
== Books == Anabolic Reference Guide. Mile High Publishing, 1991. Sports Supplement Review. Mile High Publishing, 1997. Body-for-LIFE: 12 Weeks to Mental and Physical Strength. HarperCollins, 1999. ISBN 0-06-019339-5 Body for Life Success Journal. HarperCollins, 2002. ISBN 0-06-051559-7 Eating for Life: Your Guide to Great Health, Fat Loss and Increased Energy! High Point Media, 2003. ISBN 0-9720184-1-7 Transformation: A Path from Physical to Spiritual Well-Being. Hay House, 2010. ISBN 978-1-4019-1176-8
==== 3100–3199 ==== Credit Unions (Authorised Investments) Order 1993 (S.I. 1993/3100) Education (Schools Conducted by Education Associations) (Initial Articles of Government) Regulations 1993 (S.I. 1993/3101) Education (Grant-maintained Schools) (Initial Governing Instruments) Regulations 1993 (S.I. 1993/3102) Education (Schools Conducted by Education Associations) Regulations 1993 (S.I. 1993/3103) Education (Application of Financing Schemes to Special Schools) Regulations 1993 (S.I. 1993/3104) Education (School Curriculum and Assessment Authority) (Orders for Transfer of Property and Staff) Order 1993 (S.I. 1993/3105) Education Act 1993 (Commencement No. 2 and Transitional Provisions) Order 1993 (S.I. 1993/3106) Education (School Government) (Amendment) Regulations 1993 (S.I. 1993/3107) Local Government (Compensation for Premature Retirement) (Amendment) (No. 2) Regulations 1993 (S.I. 1993/3108) Insurance Companies (Pension Business) (Transitional Provisions) (Amendment) Regulations 1993 (S.I. 1993/3109) Stamp Duty Reserve Tax (Amendment) Regulations 1993 (S.I. 1993/3110) Friendly Societies (Modification of the Corporation Tax Acts) (Amendment) Regulations 1993 (S.I. 1993/3111) Friendly Societies (Provisional Repayments for Exempt Business) Regulations 1993 (S.I. 1993/3112) Education (Publication of School Proposals and Notices) Regulations 1993 (S.I. 1993/3113) Education Assets Board (Transfers under the Education Reform Act 1988) (Amendment) Regulations 1993 (S.I.
== External links == Edward Calvin Kendall Biography Edward Calvin Kendall on Nobelprize.org "The Lasker Foundation – Clinical Medical Research Award". Retrieved June 6, 2008. "The Passano Foundation, Inc". Retrieved June 6, 2008. [1]
==== Topical ==== Cocaine is used in medical practice as a topical medication. Because it is not absorbed into the bloodstream in significant amounts when used this way, topical application does not produce the psychoactive effects associated with recreational cocaine use.
The study of chemical kinetics is used to determine the rate law for a reaction. The rate law provides a quantitative relationship between the rate of a chemical reaction and the concentrations or pressures of the chemical species present. Rate laws must be determined by experimental measurement and generally cannot be elucidated from the chemical equation. The experimentally determined rate law refers to the stoichiometry of the transition state structure relative to the ground state structure. Determination of the rate law was historically accomplished by monitoring the concentration of a reactant during a reaction through gravimetric analysis, but today it is almost exclusively done through fast and unambiguous spectroscopic techniques. In most cases, the determination of rate equations is simplified by adding a large excess ("flooding") all but one of the reactants.
Sources: en.wikipedia.org
Mass spectrometry establishes whether the observed molecular weight matches the calculated sequence mass. Chromatographic retention and fragment mapping add further confidence about sequence and composition. A single technique alone is rarely treated as sufficient evidence of identity.
Dry powder is markedly more stable than solution and is usually held frozen and desiccated. Room temperature exposure over days degrades it more slowly than most people assume, but long-term integrity favors freezer storage. Light protection is recommended regardless of temperature.
Methods, columns, gradients, and detection wavelengths are not standardized across laboratories. Some figures describe only the main peak area at one wavelength and ignore water, salts, or counter-ions. Without stated conditions, comparing reported percentages across sources is unreliable.
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.